140 related articles for article (PubMed ID: 6318419)
1. Immunity to canine adenovirus respiratory disease: effect of vaccination with an inactivated vaccine.
Cornwell HJ; Paterson SD; McCandlish IA; Thompson H; Wright NG
Vet Rec; 1983 Nov; 113(22):509-12. PubMed ID: 6318419
[TBL] [Abstract][Full Text] [Related]
2. Immunity to canine adenovirus respiratory disease: a comparison of attenuated CAV-1 and CAV-2 vaccines.
Cornwell HJ; Koptopoulos G; Thompson H; McCandlish IA; Wright NG
Vet Rec; 1982 Jan; 110(2):27-32. PubMed ID: 6280370
[TBL] [Abstract][Full Text] [Related]
3. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
4. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
5. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
[TBL] [Abstract][Full Text] [Related]
6. Use of canine adenovirus type 2 vaccine to control kennel cough syndrome.
Powell KW
Vet Med Small Anim Clin; 1979 Jun; 74(6):801-4. PubMed ID: 223268
[No Abstract] [Full Text] [Related]
7. Adenovirus 2, Bordetella bronchiseptica, and Parainfluenza Molecular Diagnostic Assay Results in Puppies After vaccination with Modified Live Vaccines.
Ruch-Gallie R; Moroff S; Lappin MR
J Vet Intern Med; 2016; 30(1):164-6. PubMed ID: 26692461
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
[TBL] [Abstract][Full Text] [Related]
9. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
[TBL] [Abstract][Full Text] [Related]
10. Serum antibody titres to canine parvovirus, adenovirus and distemper virus in dogs in the UK which had not been vaccinated for at least three years.
Böhm M; Thompson H; Weir A; Hasted AM; Maxwell NS; Herrtage ME
Vet Rec; 2004 Apr; 154(15):457-63. PubMed ID: 15119729
[TBL] [Abstract][Full Text] [Related]
11. Vaccination at different anatomic sites induces different levels of the immune responses.
Jin H; Xu Y; Shi F; Hu S
Res Vet Sci; 2019 Feb; 122():50-55. PubMed ID: 30453180
[TBL] [Abstract][Full Text] [Related]
12. Cross-protective immunity to canine adenovirus type 2 by canine adenovirus type 1 vaccination.
Emery JB; House JA; Brown WR
Am J Vet Res; 1978 Nov; 39(11):1778-83. PubMed ID: 216291
[No Abstract] [Full Text] [Related]
13. Observations on the use of an inactivated canine parvovirus vaccine.
Smith JR; Johnson RH
Vet Rec; 1986 Apr; 118(14):385-7. PubMed ID: 3012850
[TBL] [Abstract][Full Text] [Related]
14. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
Larson LJ; Schultz RD
Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
[TBL] [Abstract][Full Text] [Related]
15. Active immunization against enteric and respiratory disease of cattle with BVD, IBR and adenovirus vaccines.
Bartha A
Vet Med Nauki; 1975; 12(3):60-1. PubMed ID: 164727
[No Abstract] [Full Text] [Related]
16. Development of hypertrophic osteodystrophy and antibody response in a litter of vaccinated Weimaraner puppies.
Harrus S; Waner T; Aizenberg ; Safra N; Mosenco A; Radoshitsky M; Bark H
J Small Anim Pract; 2002 Jan; 43(1):27-31. PubMed ID: 11833821
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
18. Long-lived immunity to canine core vaccine antigens in UK dogs as assessed by an in-practice test kit.
Killey R; Mynors C; Pearce R; Nell A; Prentis A; Day MJ
J Small Anim Pract; 2018 Jan; 59(1):27-31. PubMed ID: 29087557
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
[TBL] [Abstract][Full Text] [Related]
20. High-cell-passage canine coronavirus vaccine providing sterilising immunity.
Pratelli A
J Small Anim Pract; 2007 Oct; 48(10):574-8. PubMed ID: 17877547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
